Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, Manufactured by: Laurus Labs Limited, Anakapalli-531011, India, NDC 64980-411-10
Published June 12, 2024 · Recall initiated: May 16, 2024
Summary
FDA records drug Class III recall D-0541-2024, published June 12, 2024 and initiated May 16, 2024. Recalling firm: Rising Pharma Holding, Inc.; Status: Ongoing; Reported quantity: N/A; Lot: Lot: 23132611, Exp 07/31/2026. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.
What to do
Voluntary: Firm initiated
Get an email if PREGABALIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PREGABALIN
- Manufacturer
- Rising Pharma Holding, Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0364980413107
- Lot
- Lot: 23132611, Exp 07/31/2026
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACephalexin for Oral Suspension, USP, 250mg/5mL, Rx only, 200mL (when mixed), Each contains cephalexinJune 12, 2024
- FDAEstradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila HealthcareJune 12, 2024
- FDACephalexin for Oral Suspension, USP, 250mg per 5mL, Rx only, 100mL (when mixed), Each contains cephalexinJune 12, 2024
- FDAEstradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila HealthcareJune 12, 2024
- FDAPregabalin Capsules, 50 mg, 100 count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.,January 12, 2022
- FDAPREGABALIN CAPSULES 300MG 90 ; NDC 43598-298-90; RX; CAPSULESJune 2, 2021
Questions about this recall
Was Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, Manufactured by: Laurus Labs Limited, Anakapalli-531011, India, NDC 64980-411-10 recalled?
Yes. FDA published recall D-0541-2024 on June 12, 2024. Reported hazard: Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PREGABALIN. UPC: 0364980413107.